1. Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors
   David J Stewart et al, 2014, Clinical Epigenetics CrossRef
2. Age-associated impairment of antitumor immunity in carcinoma-bearing mice and restoration by oral administration of Lentinula edodes mycelia extract
   Satoru Ishikawa et al, 2016, Cancer Immunology, Immunotherapy CrossRef
3. Molecular Pathology of Cervical Dysplasia and Carcinoma
   Yimin Ge et al, 2017, Precision Molecular Pathology of Uterine Cancer CrossRef
4. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer
   Samatha Bhat et al, 2016, Biochimie CrossRef
5. Characterization of regulatory sequences in alternative promoters of hypermethylated genes associated with tumor resistance to cisplatin
   MOHAMMED A. IBRAHIM-ALOBAIDE et al, 2015, Molecular and Clinical Oncology CrossRef
6. MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
   Shaohua Xu et al, 2015, Oncotarget CrossRef
7. A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
   Valerie Lee et al, 2018, Clinical Cancer Research CrossRef
8. 5-Aza-2′-Deoxycytidine Enhances Maspin Expression and Inhibits Proliferation, Migration, and Invasion of the Bladder Cancer T24 Cell Line
   Huihui Zhang et al, 2013, Cancer Biotherapy and Radiopharmaceuticals CrossRef